[Current problems on interferon research].
The Interferon is a biological response modifier (BRM) rather than a antibio-chemotherapeutic substance. Or, in other words, it may be a member of "hormonal immune interferon prostaglandin (HIIP)" multisystem in animal body. The author wishes to pick up the problems on clinical researches of human interferons (alpha, beta and gamma type) from the view point of BRM. So, main theme is the optimal posology and combined method of interferons and other therapies in viral diseases and especially on cancer patients.
D000818:Animals; D003520:Cyclophosphamide / Q000008:administration & dosage; D006801:Humans; D007369:Interferon Inducers; D007370:Interferon Type I / Q000627:therapeutic use; D007371:Interferon-gamma / Q000627:therapeutic use; D007372:Interferons; D007376:Interleukin-2; D008223:Lymphoma / Q000628:therapy; D051379:Mice; D012106:Research
D007369:Interferon Inducers; D007370:Interferon Type I; D007376:Interleukin-2; D007371:Interferon-gamma; D003520:Cyclophosphamide; D007372:Interferons